Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Losartan in Mild to Moderate Hypertension
NCT00887250Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Dec 1991
- Primary completion
- Aug 1992
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of losartan in hypertension (HTN), sponsored by Merck & Co.. Started Dec 1991; status: completed.
02
Drugs
losartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00887250.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00887250.